Back
Janux Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
JANX
Janux Therapeutics
Last Price:
$27.78
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.92 | Buy |
20-day SMA: | 24.43 | Buy |
50-day SMA: | 24.7 | Buy |
200-day SMA: | 38.52 | Sell |
8-day EMA: | 22.89 | Buy |
20-day EMA: | 14.4 | Buy |
50-day EMA: | 7.12 | Buy |
200-day EMA: | 1.99 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.37 | Buy |
Relative Strength Index (14 RSI): | 66.52 | Buy |
Chaikin Money Flow: | 598851 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.09 - 25.79) | Buy |
Bollinger Bands (100): | (24.07 - 30.93) | Buy |
Janux Therapeutics Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 27.75 while JANX 8-day simple moving average is 25.92, which is a Buy signal.
-
The stock price of JANX is 27.75 while Janux Therapeutics 20-day SMA is 24.43, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 24.70 while JANX share price is 27.75, making it a Buy technically.
-
JANX stock price is 27.75 and Janux Therapeutics 200-day simple moving average is 38.52, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Buy
53
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a BuyThe current Janux Therapeutics [JANX] share price is $27.75. The Score for JANX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
27.75
Share Volume:
859.2K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.48
Buy
53
Janux Therapeutics (JANX)
is a Buy
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 27.75 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is not overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 27.75 while JANX 8-day exponential moving average is 22.89, which is a Buy signal.
-
The stock price of JANX is 27.75 while Janux Therapeutics 20-day EMA is 14.40, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 7.12 while JANX share price is 27.75, making it a Buy technically.
-
JANX stock price is 27.75 and Janux Therapeutics 200-day simple moving average is 1.99, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.65 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 7.37, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 66.52, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is (23.09 - 25.79), which suggest Janux Therapeutics is a Buy
-
The Bollinger Bands (100) for Janux Therapeutics is (24.07 - 30.93), which suggest Janux Therapeutics is a Buy
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.